Proteomic-based stratification of intermediate-risk prostate cancer patients
Q. Zhong, S. Rui, A. T. Aref…·P. J. Wild
The paper identifies an 18-protein signature from proteomic data to stratify intermediate-risk prostate cancer patients into low- and high-risk groups for biochemical recurrence.